Evidence map›Paper›PMID 39890778›Full record

ArticleNature communications2025

A multi-omics spatial framework for host-microbiome dissection within the intestinal tissue microenvironment.

Bokai Zhu, Yunhao Bai, Yao Yu Yeo, Xiaowei Lu, Xavier Rovira-Clavé, Han Chen, Jason Yeung, Dingani Nkosi, Jonathan Glickman, Antonio Delgado-Gonzalez and 5 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Fujita medical journal · 2026
    Article
  14. Review
  15. Review
  16. Spatial architecture of development and disease.Nature reviews. Genetics · 2026
    Review
  17. Review
  18. Review
  19. Review
  20. Frontiers in microbiology · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Bokai ZhuRagon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA.ORCID http://orcid.org/0000-0003-3599-9419
Yunhao BaiBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Yao Yu YeoCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0002-7604-2296
Xiaowei LuMass Spectrometry Core Facility, Stanford University, Stanford, CA, USA.
Xavier Rovira-ClavéDepartment of Microbiology and Immunology, Stanford University, Stanford, CA, USA.
Han ChenDepartment of Microbiology and Immunology, Stanford University, Stanford, CA, USA.
Jason YeungCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Dingani NkosiDepartment of Pathology, Massachusetts General Brigham, Boston, MA, USA.
Jonathan GlickmanDepartment of Pathology, Massachusetts General Brigham, Boston, MA, USA.
Antonio Delgado-GonzalezDepartment of Microbiology and Immunology, Stanford University, Stanford, CA, USA.ORCID http://orcid.org/0000-0002-4760-8174
Georg K GerberDivision of Computational Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.ORCID http://orcid.org/0000-0002-9149-5509
Mike AngeloDepartment of Pathology, Stanford University, Stanford, CA, USA.ORCID http://orcid.org/0000-0003-1531-5067
Alex K ShalekRagon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA.ORCID http://orcid.org/0000-0001-5670-8778
Garry P NolanDepartment of Pathology, Stanford University, Stanford, CA, USA. gnolan@stanford.edu.ORCID http://orcid.org/0000-0002-8862-9043
Sizun JiangBroad Institute of MIT and Harvard, Cambridge, MA, USA. sjiang3@bidmc.harvard.edu.ORCID http://orcid.org/0000-0001-6149-3142

Funding

Cancer Immune Monitoring and Analysis CenterU24CA224331 · NCI · DANA-FARBER CANCER INST · PI FRANK S HODI, Catherine Ju-Ying Wu · 2017 to 2026
$18.4M
NHP CoreP01AI177687 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI Boris Dominik Juelg · 2023 to 2026
$7.4M
Single-Cell Analysis of the HIV/SIV ReservoirR01AI149670 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI BAROUCH, DAN H., SHALEK, ALEX K · 2020 to 2024
$4.6M
Defining Mechanisms of Viral Persistence in Situ at the Single-Cell LevelR01AI149672 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI ESTES, JACOB D · 2020 to 2024
$4.0M
Spatial-Temporal Dissection of Stratified Host Tissue Responses to Severe acute respiratory syndrome-related coronaviruses in situ to Understand Intra-host PathogenesisDP2AI171139 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI Sizun Jiang · 2022 to 2026
$2.3M
Probabilistic deep learning models and integrated biological experiments for analyzing dynamic and heterogeneous microbiomesR35GM149270 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI Georg Kurt Gerber · 2023 to 2026
$1.8M
Bayesian Machine Learning Tools for Analyzing Microbiome DynamicsR01GM130777 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI GERBER, GEORG KURT · 2018 to 2022
$1.6M
NCI NIH HHS U24 CA224331NIAID NIH HHS DP2 AI171139NIAID NIH HHS P01 AI177687NIAID NIH HHS R01 AI149670NIAID NIH HHS R01 AI149672NIGMS NIH HHS R01 GM130777NIGMS NIH HHS R35 GM149270
6 · The paper itself

Abstract

The intricate interactions between the host immune system and its microbiome constituents undergo dynamic shifts in response to perturbations to the intestinal tissue environment. Our ability to study these events on the systems level is significantly limited by in situ approaches capable of generating simultaneous insights from both host and microbial communities. Here, we introduce Microbiome Cartography (MicroCart), a framework for simultaneous in situ probing of host and microbiome across multiple spatial modalities. We demonstrate MicroCart by investigating gut host and microbiome changes in a murine colitis model, using spatial proteomics, transcriptomics, and glycomics. Our findings reveal a global but systematic transformation in tissue immune responses, encompassing tissue-level remodeling in response to host immune and epithelial cell state perturbations, bacterial population shifts, localized inflammatory responses, and metabolic process alterations during colitis. MicroCart enables a deep investigation of the intricate interplay between the host tissue and its microbiome with spatial multi-omics.

Indexed as

ColitisGastrointestinal MicrobiomeHost Microbial InteractionsIntestinal MucosaIntestinesAnimalsDisease Models, AnimalGlycomicsMaleMiceMice, Inbred C57BLMultiomicsProteomicsTranscriptome

Identifiers

PMID39890778
PMCPMC11785740

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.